|
UCLA Neurology :: Residency Overview
 |
RESIDENCY OVERVIEW
|
|
UCLA's clinical environment provides residents with a broad range of experience by virtue of the extensive population of patients served, the multiple facilities through which residents rotate, and the broad scope of faculty expertise. The UCLA Medical Center, which is in Westwood and on the main university campus, is a tertiary referral center for a large geographical area in Southern California and regularly receives patients from around the United States and foreign countries. Neurology patients at the Westwood facility reflect this diversity and comprise local individuals who are admitted through the emergency department, critically ill patients who are transferred from surrounding hospitals, and patients with complicated or rare conditions who are transferred, often from great distances. The UCLA Medical Center has one of the few JCAHO certified Stroke Centers. In June, 2008 a new replacement hospital opened on the Westwood campus. The new Ronald Reagan UCLA Medical Center (RRUCLAMC) is an architectural landmark, and among the most technologically advanced hospitals in the world.
|
|
| |
|
RONALD REAGAN UCLA MEDICAL CENTER VIRTUAL TOUR
|
|
Music Controller
|
|
|
|
Residents rotate through other community and county health care systems including the Greater Los Angeles Veterans Administration Medical Center, Olive View Medical Center, and the Sepulveda Veterans Administration Outpatient Medical Center. These facilities complement each other and the Westwood experience by providing a broader range of clinical experiences from patients with newly diagnosed disorders to the management of patients with chronic disease. Each facility is modern and staffed by full-time UCLA Neurology faculty. Beyond the regular rotations, residents have the opportunity to spend elective time at the UCLA Santa Monica Hospital, Cedars Sinai Medical Center, Harbor UCLA Medical Center, the private offices of clinically affiliated faculty, and centers outside of Los Angeles. There is a longstanding relationship with the National Hospital for Neurology and Neurology at Queen Square in London, UK and each year some residents spend elective time at this institution.
The Residency Training Program is structured to provide flexibility in the educational experience for each resident to tailor the overall educational program depending upon the individual's interests and career goals. This flexibility is primarily through elective time in the second and third years, which are filled by the resident's choice from many clinical or research experiences. The elective time allows residents to supplement their clinical education with more extensive training in specific areas of neurology or to participate in research. Residents may use this time to explore an area of research that is new to them or continue work that began prior to residency.
NEW RESIDENT RESEARCH TRACT
Physician-scientists occupy a critical niche in the translation of basic science findings into new clinical treatments. Within the field of neurology physician-scientists, as basic or clinical scientists, have been at the forefront, among many examples, in developing new models of human disease, developing new clinical treatments for Parkinson's disease, epilepsy and stroke and identifying novel genetic signatures of brain tumors, glial progenitors and neural stem cells that may facilitate new therapies. However, the relative and absolute numbers of physician scientists have been declining over the past 25 years, despite the doubling of the NIH research budget during a portion of this epoch. This is in large part due to the prolonged nature of the training for a physician-scientist. The Department of Neurology has recognized this problem in the creation of an NIH-funded neurology residency research track. The goal of the neurology research track is to train neurology residents in either basic or clinical science research through direct investigative study, oral and written scientific presentation and intensive mentored career development. The structure of the training program incorporates two tiers of mentoring and focused time on oral and written presentations, with a culmination in the production of a career development grant in the final year of the residency for each trainee. The program provides 6 months of consecutive research time in PGY3 or PGY4, and then an additional 18 months of funded research time that can be applied to a post-residency fellowship.
This training program is supported by an excellent environment for neuroscience research and education in the UCLA Neurology Department. The department has been the #1 NIH funded neurology department since 2002, and has a large clinical and basic research faculty with diverse and well-funded programs. The residency program is relatively large (8 per year) with flexibility to place selected residents in a research program, and has a track record of training many academic neurologists in the past. The proposed education program leverages the existing research programs of the 61 mentors in this program, and the past educational experience of the department, to develop an integrated basic and clinical science experience that provides technical training within the context of a larger translational neuroscience program within the neuroscience community at UCLA.
Applications for this program are accepted in mid August each year. Up to two applicants will then be selected to apply to the NIH/NINDS. The NIH/NINDS will fund applicants based on the available monies in this program each year, and may fund one or two applicants per year based on this funding level.
It is important to note that this is one among several research options in the UCLA Neurology Residency program. Residents can take lesser amounts of time, such as 2-4 months, for research in PGY3 or PGY4 years without necessitating any formal research program. This time can be applied toward developing lab or clinical methodologies within a mentor's research area, and applied toward an NIH K application or other post-residency career development target.
|
RESIDENCY BROCHURE |
| |
LA OFFERINGS |
| |
| |
|
|
| ( Please click "Play" to start UCLA Neurology Residency Presentation. Click "Pause" button if you wish to stop and review a slide ) |
|
|
|
UCLA NEUROLOGY RESIDENCY ADMINISTRATIVE FACULTY |
| |
|
|
| |
UCLA Neurology Department Chair
John Mazziotta, MD, Ph.D
|
|
| |
|
|
|
|
|
John Mazziotta has had a distinguished career of leadership, scientific achievement and service to the neuroscientific community. Scientifically, he has helped transform our understanding of diseases of the nervous system through the use of neuroimaging. These strategies and insights have greatly advanced our basic understanding of disease mechanisms, diagnostic criteria and the manner by which one can track conventional and experimental therapies.
Dr. Mazziotta has had a leadership role in describing what has now become our understanding of the disruption of normal functional brain networks in a wide range of neurological disorders. Having had a strong leadership role in national societies and organizations as well as university governance, Dr. Mazziotta established the first Brain Mapping Center at UCLA that included all of the methods available to study human brain structure and function. He is now the Chair of one of the largest neurology departments in the United States which last year achieved the distinguished position of being first in NIH research funding. As the chair of the Scientific Program Committee for the American Academy of Neurology, Dr. Mazziotta transformed the program, invigorated its presentations and integrated basic and clinical neuroscience. This format and his innovations remain in place years after his influence began. As Editor-In-Chief of the journal NeuroImage, he and his co-editors took this fledgling publication to a position that dominates the field, with an impact factor that has been as high as nine in recent years. Adept at organizing and managing large national and international groups, he has been instrumental in organizing large symposia, consortia and task forces that have advanced both clinical and basic neuroscience.
Since beginning this work, Dr. Mazziotta has published more than 243 research papers and eight texts. He has received numerous awards and honors, including the Oldendorf Award from the American Society of Neuroimaging, the S. Weir Mitchell Award, the Wartenberg Prize of the American Academy of Neurology, the Von Hevesy Prize from the International Society of Nuclear Medicine, and the 1996 Medical Science Award from the UCLA Medical Alumni Association. Dr. Mazziotta has been president and a founding member of the Institute for Clinical PET (positron emission tomography), the past chair of the Scientific Issues and Program Committee of the American Academy of Neurology, the past president of the American Neuroimaging Society and the President of the Organization for Human Brain Mapping. Dr. Mazziotta was elected to the prestigious Institute of Medicine of the National Academy of Sciences and the Royal College of Physicians.
|
|
| |
|
| |
|
|
| |
Program Director
Alon Y. Avidan MD, MPH Residency Training Program
|
|
| |
|
|
Phone: Fax: |
(310) 825-6681 (310) 206-4733 |
|
|
|
Dr. Avidan is currently Associate Professor of Neurology at UCLA where he serves as Director of the Neurology Residency Program, Associate Director of the Sleep Disorders Program and Director of the Neurology Clinic.
Dr. Avidan received his Bachelor of Science degree in Biology from UCLA and then attended Medical School at the George Washington University School of Medicine and Health Sciences where he also obtained a Master of Public Health. He subsequently completed his neurology Residency at the Georgetown University Medical Center, where he was Chief Resident. After residency, he completed a Fellowship in Clinical Neurophysiology and Sleep Disorders at the Cleveland Clinic Foundation.
In 1999, Dr. Avidan joined the University of Michigan where he was Assistant Professor, Director of the Sleep Disorders Clinic and chair of resident education in the Department of Neurology. Dr. Avidan was Principal Investigator of a National Heart, Lung & Blood Institute, NIH, Sleep Academic Award which helped him develop a number of educational modules for teaching sleep topics. He has guest edited two issues of Seminars in Neurology on Sleep, and had coauthored "Handbook of Sleep Medicine" and "Review of Sleep Medicine."
Dr. Avidan has developed expertise in sleep disorders in the older person. His research interests are in the field of geriatrics sleep medicine, insomnia and sleep and fatigue management in residency training. His clinical interests include management of insomnia, sleep disordered breathing, restless legs syndrome, circadian rhythm disorders, and hypersomnia.
|
|
| |
|
| |
|
|
| |
Associate Program Director
Alexander. David Residency Training Program
|
|
| |
|
|
Phone: Fax: |
(310) 825-6681 (310) 206-4733 |
|
|
|
Dr. Alexander is a neurologist whose primary clinical focus is rehabilitation neurology. Currently, he is an Associate Clinical Professor at the UCLA School of Medicine, Department of Neurology and the Medical Director of the Acute Rehabilitation Unit, Skilled Nursing Unit, and Physical Medicine at Good Samaritan Hospital. An honors graduate both of Amherst College, with a major in Neuroscience, and the University of Minnesota Medical School, Dr. Alexander was an intern in Medicine at University Hospital in Boston, and a resident in Neurology at the Neurological Institute of New York at Columbia-Presbyterian Medical Center. Dr. Alexander has board certification from the American Board of Neurology and Psychiatry in Neurology and in Vascular Neurology. In addition he has board certification from the American Board of Physical Medicine and Rehabilitation with sub-specialty certification in spinal cord medicine.
Dr. Alexander's undergraduate thesis was in amphibian visual physiology, and his research interests include the use of botulinum toxin in spasticity, novel antidepressants for post-stroke depression, and the use of acupuncture in stroke rehabilitation, and NIH sponsored research on gait training post-stroke. As an expert panel member, Dr. Alexander developed the Post-Stroke Rehabilitation: Clinical Practice Guideline, with support from the Agency for Health Care Policy and Research (AHCPR), and is Co-Chair of the Veteran's Administration/ Department of Defense Clinical Practice Guidelines for Stroke Rehabilitation.
He is a Fellow of the Stroke Council of the American Heart Association, a former site-surveyor for the Commission on Accreditation of Rehabilitation Facilities, and prior member of the Board of Directors of the American Society of Neurorehabilitation.
|
|
| |
|
| |
|
|
| |
Residency Curriculum Director
Carmichael, S.Thomas Assoc Prof-In-Rsdn
|
|
| |
|
|
Phone: Fax: |
310-794-9691 (310) 206-4733 |
|
|
|
Dr. Carmichael is an Associate Professor in the Department of Neurology at the Geffen School of Medicine at UCLA. He has an active research interest and laboratory studies in neural repair after stroke and other forms of brain injury. These research projects aim to determine the molecular and cellular mechanisms of axonal sprouting and stem cell responses after stroke, and how these two processes of neuronal regeneration lead to repair of damaged brain circuits. Dr. Carmichael also attends on the Neurorehabilitation and Stroke services at UCLA Medical Center, and has an outpatient clinic in Stroke, Neurorehabilitation and General Neurology. Dr. Carmichael obtained his M.D. and Ph.D. degree from Washington University School of Medicine. His Ph.D. work determined the structural and connectional organization of the prefrontal cortex in primates, and how these circuits are involved in affective disorders in humans. He completed a neurology residency at Washington University School of Medicine and then a postdoctoral research and clinical fellowship in neural repair and neurorehabilitation with Drs. Marie-Francoise Chesselet and Bruce Dobkin. This work was recognized by a Howard Hughes Medical Institute Postdoctoral Fellowship Award, and produced novel data on how brain injury triggers the formation of new connections with partially damaged brain areas. Currently, Dr. Carmichael's laboratory is using newly developed cellular and molecular approaches, including laser capture microdissection, microarray analysis and real-time quantitative RT-PCR, to determine the molecular components of a neuronal growth program in the adult cortex after stroke, and the cellular and molecular mechanisms of neural stem cell responses and neuroblast migration in the brain after stroke.
|
|
| |
|
| |
|
|
|
|